Amgen to discontinue discounts on anemia drug: report (Reuters)
Reuters - Amgen Inc is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product’s safety, the New York Times said.
More: continued here
Recent Entries
- Essence Fest to celebrate black music in La. (AP)
- No safe haven for rarest antelope
- Manny’s back, and Dodger fans will show the love
- England draw Bears practice match
- Manny apologizes ahead of return to Dodgers
- Schein’s Nine: Eagles finally have WRs
- Ant mega-colony takes over world
- UK-born astronauts are to receive a commemorative pin
- Palin plans to stay visible (Politico)
- Palin announces resignation (Politico)
